Cell Mol Life Sci, 2024, 81(1):437

Human TRPV1 is an efficient thermogenetic actuator for chronic neuromodulation

Thermogenetics is a promising neuromodulation technique based on the use of heat-sensitive ion channels. However, on the way to its clinical application, a number of questions have to be addressed. First, to avoid immune response in future human applications, human ion channels should be studied as thermogenetic actuators. Second, heating levels necessary to activate these channels in vivo in brain tissue should be studied and cytotoxicity of these temperatures addressed. Third, the possibility and safety of chronic neuromodulation has to be demonstrated. In this study, we present a comprehensive framework for thermogenetic neuromodulation in vivo using the thermosensitive human ion channel hTRPV1. By targeting hTRPV1 expression to excitatory neurons of the mouse brain and activating them within a non-harmful temperature range with a fiber-coupled infrared laser, we not only induced neuronal firing and stimulated locomotion in mice, but also demonstrated that thermogenetics can be employed for repeated neuromodulation without causing evident brain tissue injury. Our results lay the foundation for the use of thermogenetic neuromodulation in brain research and therapy of neuropathologies.

Maltsev DI, Solotenkov MA, Mukhametshina LF, Sokolov RA, Solius GM, Jappy D, Tsopina AS, Fedotov IV, Lanin AA, Fedotov AB, Krut VG, Ermakova YG, Moshchenko AA, Rozov A, Zheltikov AM, Podgorny OV, Belousov VV

IBCH: 11560
Ссылка на статью в журнале: https://link.springer.com/10.1007/s00018-024-05475-x
Кол-во цитирований на 09.2026: 9
Данные статьи проверены модераторами 2024-11-08

Список научных проектов, где отмечена публикация

  1. 075-15-2019-1789. . Сommercial.
  2. 23-75-30023. . Сommercial.
  3. -Термогенетическая терапия эпилепсии (January 6, 2023 — December 31, 2025). Podgornyj O.V.. Grant, RSF.
  4. 22–22-00590. . Сommercial.